PL2345425T3 - Koncentrat immunoglobulin G (IgG) zubożony w przeciwciała anty-A i anty-B oraz w polireaktywne IgG - Google Patents

Koncentrat immunoglobulin G (IgG) zubożony w przeciwciała anty-A i anty-B oraz w polireaktywne IgG

Info

Publication number
PL2345425T3
PL2345425T3 PL11162751T PL11162751T PL2345425T3 PL 2345425 T3 PL2345425 T3 PL 2345425T3 PL 11162751 T PL11162751 T PL 11162751T PL 11162751 T PL11162751 T PL 11162751T PL 2345425 T3 PL2345425 T3 PL 2345425T3
Authority
PL
Poland
Prior art keywords
immunoglobulin
igg
antibodies
polyreactive iggs
concentrate depleted
Prior art date
Application number
PL11162751T
Other languages
English (en)
Polish (pl)
Inventor
Abdessatar Chtourou
Frédéric Dhainaut
Philippe Paolantonacci
Original Assignee
Laboratoire Français Du Fractionnement Et Des Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36956126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2345425(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Français Du Fractionnement Et Des Biotechnologies filed Critical Laboratoire Français Du Fractionnement Et Des Biotechnologies
Publication of PL2345425T3 publication Critical patent/PL2345425T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
PL11162751T 2005-12-26 2006-12-26 Koncentrat immunoglobulin G (IgG) zubożony w przeciwciała anty-A i anty-B oraz w polireaktywne IgG PL2345425T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0513311A FR2895263B1 (fr) 2005-12-26 2005-12-26 Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
EP06847150.7A EP1968634B1 (fr) 2005-12-26 2006-12-26 PROCÉDÉ DE PRÉPARATION DE CONCENTRE D' IMMUNOGLOBULINES G (IgG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B
PCT/FR2006/002889 WO2007077365A2 (fr) 2005-12-26 2006-12-26 CONCENTRE D’IMMUNOGLOBULINES G (IgG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B, ET EN IgG POLYREACTIVES
EP11162751.9A EP2345425B1 (fr) 2005-12-26 2006-12-26 CONCENTRÉ D'IMMUNOGLOBULINES G (IgG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B, ET EN IgG POLYRÉACTIVES

Publications (1)

Publication Number Publication Date
PL2345425T3 true PL2345425T3 (pl) 2019-01-31

Family

ID=36956126

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06847150T PL1968634T3 (pl) 2005-12-26 2006-12-26 Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b
PL11162751T PL2345425T3 (pl) 2005-12-26 2006-12-26 Koncentrat immunoglobulin G (IgG) zubożony w przeciwciała anty-A i anty-B oraz w polireaktywne IgG

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL06847150T PL1968634T3 (pl) 2005-12-26 2006-12-26 Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b

Country Status (15)

Country Link
US (1) US8153382B2 (enExample)
EP (3) EP2792366A1 (enExample)
JP (3) JP5726403B2 (enExample)
KR (1) KR101250095B1 (enExample)
CN (3) CN102921004A (enExample)
AU (1) AU2006334278B2 (enExample)
BR (1) BRPI0620600B1 (enExample)
CA (1) CA2634997C (enExample)
DK (2) DK1968634T3 (enExample)
ES (2) ES2690664T3 (enExample)
FR (1) FR2895263B1 (enExample)
IL (2) IL192289A (enExample)
PL (2) PL1968634T3 (enExample)
TR (1) TR201814658T4 (enExample)
WO (1) WO2007077365A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
FR2939667B1 (fr) * 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
FR2940617B1 (fr) 2008-12-30 2012-04-20 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobulines g
EP2236617A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
FR2949195B1 (fr) 2009-08-24 2011-10-14 Lfb Biomedicaments Poche de stockage de solution therapeutique
FR2952826B1 (fr) 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
EP2566879A4 (en) * 2010-05-05 2013-09-11 Arryx Inc METHOD FOR FUNCTIONALIZATION OF HUMAN RED GLOBES USING ANTIBODIES
FR2959821B1 (fr) 2010-05-05 2012-07-06 Lab Francais Du Fractionnement Procede de mesure de l'activation du complement par des igg
FR2961107B1 (fr) * 2010-06-15 2012-07-27 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines stabilisee
FR2962650B1 (fr) 2010-07-19 2013-04-05 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
US20140323315A1 (en) 2013-04-29 2014-10-30 Adimab, Llc Polyspecificity reagents, methods for their preparation and use
ES2793176T3 (es) * 2013-07-05 2020-11-13 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa Matriz de cromografía de afinidad
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
FR3026950A1 (fr) * 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035794B1 (fr) * 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr) * 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035971A1 (fr) * 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
US20170066839A1 (en) * 2015-09-08 2017-03-09 Merck Patent Gmbh Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10697982B2 (en) * 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
AU2016348232A1 (en) * 2015-10-21 2018-06-07 Cambryn Biologics, Llc Processes for purifying proteins from plasma
FR3076294B1 (fr) 2017-12-29 2022-01-28 Lab Francais Du Fractionnement Procede de purification d'anticorps a partir de lait brut
CN108101981B (zh) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
CN109239335A (zh) * 2018-09-11 2019-01-18 广州万孚生物技术股份有限公司 联检试纸条及其制备方法
WO2024200757A1 (en) 2023-03-29 2024-10-03 Csl Behring Ag Methods of identifying immunoglobulin associated with adverse reactions
WO2025103611A1 (en) 2023-11-15 2025-05-22 Biotest Ag Method of manufacturing an igm containing composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR513311A (fr) 1916-05-04 1921-02-12 Raphael Von Ostrejko Procédé et installation pour la préparation de charbon décolorant
US4664913A (en) 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
DK166763C (da) 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
JPS622162A (ja) * 1985-06-28 1987-01-08 Mutsuo Kitahama 抗ｂモノクロ−ナル抗体およびその製造法
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
AT391810B (de) 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
DE59009020D1 (de) 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
AU686577B2 (en) * 1992-10-30 1998-02-12 Innogenetics, Inc. Measurement of total molecule in a sample and methods based thereon
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
CA2136698A1 (en) 1994-11-25 1996-05-26 M. Abdul Mazid Resin compositions and methods for their use
US5776711A (en) 1996-11-12 1998-07-07 The Regents Of The University Of California Simultaneous human ABO and RH(D) blood typing or antibody screening by flow cytometry
TR200100303T2 (tr) 1998-06-09 2001-06-21 Statens Serum Institut Damardan uygulanacak immünoglobülinler üretmek için yöntem ve başka immünoglobülin ürünleri.
EP1315551B1 (en) * 1999-06-03 2015-11-04 Advanced Extravascular Systems One step removal of unwanted molecules from circulating blood
FR2794461B1 (fr) * 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
DE60021098T2 (de) 1999-10-08 2006-06-14 Vi Technologies Inc Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
EP1165159B1 (en) 2000-02-08 2008-03-26 Glycorex Transplantation AB Oligosaccharide supports for e.g. removal of antibodies from blood
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
JP4493882B2 (ja) * 2001-06-19 2010-06-30 株式会社カネカ 抗原およびこの抗原を識別するモノクローナル抗体
US20040101909A1 (en) 2002-08-20 2004-05-27 Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 Purification of polyreactive autoantibodies and uses thereof
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives

Also Published As

Publication number Publication date
IL231806A (en) 2017-04-30
US20090074749A1 (en) 2009-03-19
JP2015091866A (ja) 2015-05-14
ES2690664T3 (es) 2018-11-21
BRPI0620600A2 (pt) 2011-11-16
JP5944543B2 (ja) 2016-07-05
FR2895263A1 (fr) 2007-06-29
US8153382B2 (en) 2012-04-10
JP2009521520A (ja) 2009-06-04
KR20080098486A (ko) 2008-11-10
FR2895263B1 (fr) 2008-05-30
CA2634997A1 (en) 2007-07-12
CN101346153A (zh) 2009-01-14
DK1968634T3 (da) 2014-10-13
ES2517540T3 (es) 2014-11-03
EP2345425A2 (fr) 2011-07-20
IL231806A0 (en) 2014-05-28
JP2013151507A (ja) 2013-08-08
WO2007077365A2 (fr) 2007-07-12
JP5726403B2 (ja) 2015-06-03
CA2634997C (en) 2017-07-18
CN102921004A (zh) 2013-02-13
EP2792366A1 (fr) 2014-10-22
DK2345425T3 (en) 2018-10-29
EP1968634A2 (fr) 2008-09-17
EP2345425B1 (fr) 2018-07-11
PL1968634T3 (pl) 2015-03-31
CN103394084B (zh) 2016-04-27
AU2006334278B2 (en) 2012-11-01
KR101250095B1 (ko) 2013-04-03
IL192289A0 (en) 2008-12-29
IL192289A (en) 2014-11-30
EP1968634B1 (fr) 2014-07-16
CN103394084A (zh) 2013-11-20
BRPI0620600B1 (pt) 2022-01-04
AU2006334278A1 (en) 2007-07-12
TR201814658T4 (tr) 2018-11-21
CN101346153B (zh) 2013-08-14
WO2007077365A3 (fr) 2007-08-30
EP2345425A3 (fr) 2011-12-28

Similar Documents

Publication Publication Date Title
IL231806A0 (en) Immunoglobulin (igg) concentrate depleted of anti-a and anti-b antibodies and polyreactive IgG
IL187683A (en) Methods for purifying antibodies against a beta
IL180152A0 (en) Chimeric and humanised monoclonal antibodies against inteleukin-13
IL272883A (en) Monoclonal antibodies and their uses
ZA200805526B (en) Chimeric and humanised anti-human IL-13 antibodies
IL179672A (en) Monoclonal antibodies against 3 cd human
IL178409A0 (en) Humanized anti-tgf-beta antibodies
PL1951760T3 (pl) Ludzkie przeciwciało monoklonalne wobec ludzkiego CD134 (OX40) i sposoby jego wytwarzania i stosowania
IL177602A0 (en) Uses of anti-ctla-4 antibodies
IL181625A0 (en) Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates
TWI370137B (en) Human monoclonal antibodies to activin receptor-like kinase-1
IL202232A0 (en) Novel rabbit antibody humanization methods and humanized rabbit antibodies
IL239947A (en) 21-il monoclonal antibody from human origin
IL187710A0 (en) Anti-trkb monoclonal antibodies and uses thereof
IL213618A0 (en) Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system
EP2233501A4 (en) HUMANIZED MONOCLONAL ANTI-CD34 ANTIBODIES AND THEIR PREPARATION AND APPLICATIONS
AU2013206196B9 (en) Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs
PT1718678T (pt) Anticorpo monoclonal de tenascina anti-humano
PL1899377T3 (pl) Humanizowane przeciwciała specyficzne dla nogo-a i ich zastosowania farmaceutyczne
AU2009334626B2 (en) Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system
HK1122580A (en) Chimeric and humanised anti-human il-13 antibodies
HK1108457A (en) Chimeric and humanised monoclonal antibodies against interleukin-13
HK1124340A (en) Human monoclonal antibody human cd134 (ox40) and methods of making and using same
HK1099709A (en) Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates
HK1103524A (en) Humanized anti-tgf-beta antibodies